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Subgenomic RNA transcription of coronaviruses involves the interaction between the leader (or antileader) and the
intergenic (IG) sequences. However, it is not clear how these two sequences interact with each other. In this report, a
previously unrecognized minor species of subgenomic mRNA, termed mRNA5–1, was identified in cells infected with mouse
hepatitis virus (MHV) strains JHM2c, JHM(2), JHM(3), A59, and MHV-1. Sequence analysis revealed that the leader-body
fusion site of the mRNA is located at approximately 150 nucleotides (nt) downstream of the consensus IG sequence for
mRNA 5 and did not have sequence homology with any known IG consensus sequences. To determine whether this
sequence functions independently as a promoter, we cloned a 140-nt sequence (from ’70 nt upstream to ’70 nt
downstream of the fusion site) from viral genomic RNA and placed it in front of a reporter gene in the defective-interfering
(DI) RNA-chloramphenicol acetyltransferase (CAT) reporter vector. Transfection of the reporter RNA into MHV-infected cells
resulted in synthesis of a CAT-specific subgenomic mRNA detected by reverse transcription-polymerase chain reaction
(RT-PCR). The strength of this promoter was similar to that of the IG7 (for mRNA 7) as measured by the CAT activity. Deletion
analysis showed that the sequence as few as 13 nt was sufficient to initiate mRNA transcription, while mutations within the
13-nt abolished mRNA transcription. In vitro translation study confirmed that the envelope (E) protein was translated from
mRNA5–1, which encodes the open reading frame (ORF) 5b at its 59-end, indicating that mRNA5–1 is a functional message.
Furthermore, when the ORF5b was replaced with the CAT gene and placed in the DI in the context of viral mini-genome, CAT
was expressed not only from the first ORF of mRNA5–1 but also from the second and third ORF of mRNA5 and genomic DI
RNA, respectively, suggesting that more than one mechanism is involved in regulation of ORF5b expression. Our findings thus
support the notion that base-pairing between the leader (or antileader) and the IG is not the sole mechanism in subgenomic
RNA transcription. © 2000 Academic PressINTRODUCTION
Mouse hepatitis virus (MHV), a prototype of murine
coronavirus, contains a single-strand, positive-sense
RNA genome of ’32 kb in length (Lee et al., 1991;
Pachuk et al., 1989). Upon virus infection into susceptible
cells, the viral genomic RNA serves both as an mRNA for
translation of the putative RNA-dependent RNA polymer-
ase polyprotein, which is required for subsequent RNA
transcription and replication, and as a template for the
synthesis of the genome-length, negative-strand RNA
that in turn is used for the synthesis of the viral genome.
Six to seven subgenomic mRNAs (mRNAs 2 to 7) are
found in MHV-infected cells (Lai et al., 1981; Leibowitz et
al., 1981). They are co-nested at the 39-ends (Lai et al.,
1981; Leibowitz et al., 1981). Each mRNA contains a
leader sequence of approximately 70 nucleotides (nt) at
the 59-end, which is identical to the leader sequence of
1 To whom reprint requests should be addressed at Department of
icrobiology and Immunology, University of Arkansas for Medical
ciences, 4301 W. Markham St., Slot 511, Little Rock, AR 72205. Tele-
hone: (501) 686-7415. Fax: (501) 686-5359. E-mail: zhangxuming@
xchange.uams.edu
75the genomic RNA (Lai et al., 1983, 1984; Spaan et al.,
1983). Depending on MHV strains, there are two to four
consensus UCUAA repeats with the last repeat being
UCUAAAC, at the 39-end of the leader (Makino and Lai,
1989a,b). An identical or similar consensus sequence is
present between each gene, termed intergenic (IG) se-
quence (Budzilowicz et al., 1985; Shieh et al., 1989),
which serves as a transcription initiation signal (pro-
moter) for subgenomic mRNA synthesis (based on the
leader-primed transcription model) or a termination sig-
nal for subgenomic negative-strand RNA synthesis
(based on the discontinuous transcription on the nega-
tive-strand RNA) (Lai and Cavanagh, 1997, and refer-
ences therein). The IG is the cis-acting sequence abso-
lutely required for subgenomic RNA transcription
(Makino et al., 1991); it serves as a joining point between
the leader (or antileader) and the remaining body part of
each subgenomic RNA. For simplicity and consistency,
we use the terminology according to the leader-primed
transcription model (Lai and Cavanagh, 1997) throughout
this report.
Direct sequencing of viral mRNAs have revealed vary-
ing numbers of UCUAA repeats at the 39-end of the
leader among certain subgenomic mRNA species of
0042-6822/00 $35.00
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76 ZHANG AND LIUJHM and JHM2c (Makino et al., 1988, 1989a,b), the latter
of which is a naturally occurring small plaque mutant of
JHM (Makino et al., 1984). Further sequencing on cDNA
clones derived from JHM2c mRNAs by reserve transcrip-
tion-polymerase chain reaction (RT-PCR) has shown that
the leader-body joining sites in subgenomic mRNA2–1
are more heterogeneous (Zhang and Lai, 1994). In addi-
tion to the varying numbers of repeats, the joining sites
of some mRNAs are located either upstream or down-
stream of the authentic consensus IG sequence, and
they appear to be randomly distributed. The degree of
such heterogeneity varies among JHM strains and mRNA
species. Such phenomenon has also been observed in a
recombinant MHV A59 expressing a green fluorescence
protein (Fischer et al., 1997). Two mRNA species smaller
han mRNA7 were also identified in MHV-infected cells;
hey initiate from IG-like sequences UCCAAAC and
CUAAAU, respectively, within the nucleocapsid gene
Schaad and Baric, 1993). Thus, heterogeneity of leader-
ody joining sites in subgenomic mRNAs may be a
ommon phenomenon for MHV.
The genomic and subgenomic mRNAs of coronavi-
uses are capped and contain multiple open reading
rames (ORFs). In general, only the 59-most ORF of each
RNA is translated into a protein via the cap-dependent
ibosomal scanning mechanism, while the downstream
RFs are not translatable (Lai and Cavanagh, 1997, and
eferences therein). An exception was found with the
RF5b of MHV, which encodes the E (envelope) protein.
he E is a structural protein (Yu et al., 1994) and is
essential for virion assembly (Vennema et al., 1996). It
as found to be translated from the second ORF of the
icistronic mRNA5 in vitro (Thiel and Siddell, 1994, 1995),
uggesting that translation of the E protein is cap-inde-
endent, possibly via an internal ribosomal entry site
IRES). Subsequently, the IRES has been roughly mapped
hrough a series of deletion mutants to be located ap-
roximately between 100-nt upstream and 180-nt down-
tream of initiation codon for ORF5b (Jendrach et al.,
1999). The counterparts of the E gene in other coronavi-
ruses include ORF5b of bovine coronavirus (BCoV), ORF4
of transmissible gastroenteritis virus (TGEV) and human
coronavirus (HCoV) 229E, and ORF3c of avian infectious
bronchitis virus (IBV) (Godet et al., 1992; Smith et al.,
1990; Siddell, 1995). Interestingly, while ORF5b of BCoV
and ORF4 of TGEV and HCoV are translated from the first
ORF of mRNA5–1 and mRNA4, respectively, the ORF3c of
IBV and ORF5b of MHV are translated from the third and
second ORF of mRNA3 and mRNA5, respectively. More
intriguingly, within TGEV strains, the ORF3b of Muller
strain is translated from the second ORF of mRNA3 via
an IRES, whereas that of the Purdue strain is translated
from the first ORF of mRNA3–1 via cap-dependent mech-
anism (O’Connor and Brian, 2000). It is not known, how-
ever, why strains of the same TGEV or of various coro-
1
enaviruses evolved such distinct mechanisms in regula-
tion of their gene expression.
During the course of studying MHV transcriptional
regulation, we unexpectedly identified a minor species of
subgenomic mRNA in JHM2c-infected cells. Subse-
quently, the same mRNA species was identified in other
MHV strains. We found that the leader-body joining site
for this mRNA is located approximately 150-nt down-
stream rather than the authentic consensus IG sequence
for mRNA5. We thus named mRNA5–1 for this novel
mRNA species, and accordingly, IG5–1 for this transcrip-
tion initiation site. When it was placed in front of the
chloramphenicol acetyl-transferase (CAT) gene in the
defective-interfering (DI) RNA-CAT reporter plasmid, the
IG5–1, which is devoid of any known IRES sequence, can
direct the synthesis of a subgenomic CAT-containing
mRNA and expression of the CAT activity, thus confirm-
ing that the IG5–1 serves as a promoter for transcription
of a subgenomic mRNA. Deletion analyses identified that
a 13-nt sequence is sufficient for driving the reporter
gene transcription. Furthermore, in vitro translation study
onfirmed that the E protein is translated from mRNA5–1,
uggesting that mRNA5–1 is likely a functional message
n virus-infected cells.
RESULTS
Heterogeneity of mRNA5 transcripts of MHV JHM2c in
nfected cells. Previous studies have shown that sub-
enomic mRNA2–1 of a small plaque mutant JHM2c is
ore heterogeneous in the leader-body joining site than
hat of its parental JHM strain, and that, even within the
ame JHM2c strain, mRNA2–1 is more heterogeneous
han mRNA7 (Zhang and Lai, 1994). To understand
hether such heterogeneity is virus-strain specific or
RNA-species specific, we have undertaken systematic
nalyses on the structure of all subgenomic mRNA spe-
ies of JHM2c. DBT cells were infected with JHM2c at a
ultiplicity of infection (m.o.i.) of 5 in the presence of
ctinomycin D. Intracellular RNAs were extracted from
nfected cells at 8 h postinfection (p.i.). cDNAs were
mplified by reverse transcription-polymerase chain ac-
ion (RT-PCR) with a sense primer specific to the leader
equence and an antisense primer specific to a se-
uence downstream of the IG for each subgenomic
RNA. PCR products were directly cloned into the
TOPO2.1 TA vector. Inserts were then released from the
ector by digestion with a restriction endonuclease
coRI and were analyzed by agarose gel electrophore-
is. We found that heterogeneity of subgenomic mRNAs
ccurred in all mRNA species (Fig. 1, and further data not
hown). While it was consistent with the previous finding
hat the heterogeneity at the leader-body fusion site
ppeared to be randomly distributed (Zhang and Lai,
994), transcripts amplified from mRNA5-specific primers
xhibited another distinct subset. As shown in Fig. 1B,
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77A NONCANONICAL SIGNAL FOR MHV RNA TRANSCRIPTIONthree types of cDNA inserts for mRNA5 were identified.
Fourteen of the 20 clones analyzed had a size corre-
sponding to mRNAs initiating at the authentic consensus
IG5 site. One had a size larger than the authentic
mRNA5. Surprisingly, a quarter (5/20) of clones had a
size smaller than the authentic mRNA5, suggesting that
these transcripts possibly initiated at a downstream se-
quence. These results indicate that mRNA 5 of JHM2c is
also heterogeneous, but that a second initiation site
might be present at a downstream location.
A noncanonical sequence downstream of the consen-
sus intergenic sequence for mRNA5 likely serves as a
leader-body fusion site for a smaller species of sub-
genomic mRNA. To confirm that the cDNA clones shown
in Fig. 1 indeed represent mRNA5, and if so, what are the
structural feature of these clones at the leader-body
joining sites, all 20 clones were sequenced with an
automated DNA sequencer. As shown in Fig. 2A, all 20
clones contained sequences corresponding to mRNA5
of JHM2c, indicating the specificity of the RT-PCR prod-
ucts. Consistent with the data from agarose gel analysis
(Fig. 1), the leaders of the 14 clones fused to the body at
the authentic consensus IG sequence (UCUAAAC) (Fig.
2A). In one clone, the leader fused to a sequence up-
stream of the consensus IG sequence. This clone was
not pursued for further experiments due to its singularity.
FIG. 1. Heterogeneity of subgenomic mRNA 5 of MHV JHM2c. (A)
Schematic diagram depicting the structure of the genome and sub-
genomic mRNA5. IG5-CS, intergenic consensus sequence for tran-
scription of mRNA5. The two primers used for RT-PCR and the pre-
dicted size of the PCR products are shown. 5a and 5b, open reading
frame 5a and 5b. Leader, leader RNA. (B) Results of agarose gel
electrophoresis analysis. PCR products from (A) were cloned into the
pTOPO2.1 TA cloning vector. Plasmid DNAs were isolated from individ-
ual colonies, digested with EcoRI (two EcoRI sites franking the cloning
site of the vector), and analyzed by electrophoresis on a 2% agarose
gel. Arrows indicate the vector and the released inserts. Molecular
weight marker in base pair (bp) is shown on the left.All the other five smaller clones had a leader fused to a
nonconsensus sequence approximately 150-nt down-stream of the authentic consensus IG sequence, with
only three nucleotides complementary to the template
(Figs. 2A and 2B). These sequence data indicate that the
noncanonical downstream sequence possibly serves as
a site for leader-fusion for a smaller subgenomic mRNA
species, which is termed mRNA5–1.
To further determine whether mRNA5–1 is transcribed
also in other MHV strains, DBT cells were infected with
JHM(2), JHM(3), A59, and MHV-1 at m.o.i. of 5. Intracel-
lular viral RNAs were isolated. The primer pair 59-L9 and
39-IG6–50 was used for amplifying the 59-end of
mRNA5–1 in RT-PCR. Two rounds of PCR for a total of 65
cycles were performed. The PCR fragments of ’600 nt in
ength were gel-purified and used for direct sequencing.
s shown in Figs. 2C–2F, the DNA fragments of the four
HV strains contain the same leader-body junction site
hat is identical to that of the IG5–1 of JHM2c (see Fig.
B). These results thus confirm the existence of
RNA5–1 in all five MHV strains studied that uses the
ownstream IG5–1 sequence as the leader-fusion site. It
s worth noting that minor species of mRNAs other than
RNA5–1 might exist, which could not be identified by
irect sequencing of PCR fragments.
The noncanonical transcriptional signal is a functional
romoter for the synthesis of a subgenomic mRNA in a DI
NA-CAT reporter system. To test whether this nonca-
onical sequence can serve as a transcription initiation
ite (promoter) for a reporter gene, a sequence of 140-nt
ncompassing approximately 70 nt each of the upstream
nd downstream of the leader-fusion site was placed in
ront of a CAT reporter gene in a DI RNA vector (Liao and
ai, 1994; Zhang et al., 1994). The DI RNA-CAT reporter
ystem has been extensively used for studying MHV
eplication, transcription, and gene expression (Liao and
ai, 1994; Liao et al., 1995; Zhang and Lai, 1994; Zhang et
al., 1994, 1997, 1998). If the noncanonical signal serves
as a promoter, a CAT-containing subgenomic mRNA
would be transcribed in helper MHV-infected cells and
the CAT activity would be expressed. As shown in Fig.
3A, the CAT activity expressed from DECAT5–1-trans-
fected cells was as high as that from DECAT7, which
contains the promoter sequence for transcription of
mRNA 7 (Zhang et al., 1994). This result indicates that the
40-nt noncanonical sequence drives the expression of
he CAT gene in the DI RNA reporter plasmid.
Because it is reported that MHV ORF5b is translated
rom mRNA5 via an IRES sequence (Thiel and Siddell,
994, 1995), it is important to determine whether the CAT
ctivity resulted from translation of the bicistronic DI RNA
r of a separate subgenomic mRNA, even though this
40-nt sequence does not contain the IRES sequence
ecently identified by Jendrach et al. (1999). To directly
identify the CAT-containing subgenomic mRNAs, RNAs
were isolated from MHV-infected and DECAT5–1 RNA-
transfected cells. RNAs isolated from DECAT7 RNA-
transfected cells and from mock-transfected cells were
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78 ZHANG AND LIUused as positive and negative controls, respectively.
Subgenomic mRNAs were then amplified by RT-PCR with
a CAT-specific antisense primer and a leader-specific
sense primer. As shown in Fig. 3B, a specific sub-
genomic mRNA containing the CAT gene was identified
in DECAT5–1 RNA- and DECAT7 RNA-transfected cells
but not in the mock-transfected cells, indicating that a
FIG. 2. Summary of the DNA sequencing results. (A) Heterogene
equencing. Template is shown in (2)-strand. Only the consensus sequ
or mRNA5–1 (IG5–1) are shown. Vertical lines indicate the complemen
o each mRNA species indicates the number of clones, which represent
epresentative sequencing profiles showing the leader-body fusion sit
espectively. DNA sequencing was carried out in the automatic DNA s
romoter primer (B) or directly using gel-purified PCR fragments with pr
The leader and mRNA body sequences are indicated with arrows in red
in blue.CAT-containing subgenomic mRNA was specifically tran-
scribed from the 140-nt sequence of DECAT5–1. Thisresult demonstrates that the noncanonical sequence can
serve as an initiation signal (promoter) for subgenomic
mRNA transcription in a DI RNA-reporter system.
Mutational analysis of the transcriptional initiation sig-
nal. To identify the minimal sequence required for sub-
genomic mRNA transcription, three deletions within the
140-nt sequence were made by PCR, and the deletion
der-body fusion sites of JHM2c mRNA5 species revealed by DNA
f the intergenic region 5 (IG5-CS) and the transcriptional initiation site
uences at the leader-body fusion site. The number shown on the right
responding mRNA species. A total of 20 clones were sequenced. (B–F),
NA5–1 for JHM2c (B), JHM(2) (C), JHM(3) (D), A59 (E), and MHV-1 (F),
cer (ABI Prism Model 377) using the cloned plasmid DNAs with a T7
IG6–50 (C–F). The consensus repeat sequence is underlined in green.
e, respectively. The three nucleotides (AAT) at the fusion site are boxedous lea
ence o
tary seq
the cor
e of mR
equen
imer 39fragments were cloned into the DI RNA-CAT reporter
vector in place of the wild-type, full-length (140-nt) se-
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79A NONCANONICAL SIGNAL FOR MHV RNA TRANSCRIPTIONquence (Fig. 4A). The ability of the deleted sequences in
initiating subgenomic mRNA transcription was then de-
termined by both the expression of CAT activity and the
synthesis of CAT-containing subgenomic mRNAs. As
shown in Fig. 4A, when an upstream 63-nt sequence was
deleted, the CAT activity was similar to that of the full-
length [compare DECAT5–1(140) with DECAT5–1D63].
owever, when an additional 13-nt sequence was de-
eted, the CAT activity was significantly reduced to ap-
roximately 12-fold above the background (more than
00-fold reduction) [compare DECAT5–1D76 with
ECAT5–1D63 in Fig. 4A). When a construct containing
nly a 13-nt sequence franking the leader-fusion site was
ransfected [construct DECAT5–1(13)], 95% of the CAT
ctivity was expressed as compared to the full-length
DECAT5–1(140)], indicating that the 13-nt sequence is
ufficient for driving CAT expression. Consistent with the
esults of CAT activity, subgenomic mRNAs correspond-
ng to the respective constructs were identified by RT-
CR in MHV-infected and DI-transfected cells (Fig. 4B).
he noncanonical transcription initiation signal, there-
ore, contains not more than 13 nt and encompasses the
FIG. 3. The noncanonical sequence is a functional promoter for
subgenomic mRNA transcription in the defective-interfering (DI) RNA
chloramphenicol-acetyltransferase (CAT)-reporter system. (A) The
names of the DI RNA CAT reporters are shown on the left and their
structures in the middle. CAT activities expressed from these con-
structs, shown on the right, represent fold-increase against the back-
ground, which is set as onefold (13). The CAT activities are represen-
tative of three independent experiments. IG5–1 and IG7 indicate the
transcription initiation sites for mRNA5–1 and mRNA7, respectively.
ORF, DI open reading frame. (B) Reverse-transcription PCR was per-
formed to detect CAT-containing subgenomic mRNAs using CAT- and
leader-specific primers. PCR products were analyzed by electrophore-
sis on a 1% agarose gel. Lanes Mock-Tx, DECAT5–1(140), and DECAT7
are the RT-PCR products from helper JHM-infected and mock-,
DECAT5–1(140) RNA-, and DECAT7 RNA-transfected cells, respectively.
M, molecular mass marker in base pair (bp) is shown on the left.eader-joining site.
To further determine whether this 13-nt core sequenceis specifically required for mRNA transcription, three
mutations (-GGUUA- to –GGCGC-) were introduced by
PCR-based site-directed mutagenesis. When the mutant
DI RNA [DECAT5–1(13)m] was transfected, CAT activity
expressed from this RNA was drastically decreased (71-
fold reduction) (Fig. 4A). No CAT-containing subgenomic
mRNA was detectable by RT-PCR (Fig. 4B). These results
indicate that the three nucleotides in this core sequence
are required for its transcription activity.
Subgenomic mRNA5–1 is a functional message for
translation of the E protein in an in vitro translation
system. To determine whether mRNA 5–1 is a functional
message, the open reading frame prediction program of
software MacVector (version 3.5) was used to analyze
the sequence and to predict the possible ORFs in
mRNA5–1. Our analysis indicated that ORF5b is the most
probable ORF at the 59-end of mRNA5–1 (Fig. 5A). To
confirm that ORF5b can be expressed from mRNA5–1, a
FIG. 4. Deletion mapping of the noncanonical transcription signal. All
deletion mutants were made and their transcription activities were
examined in the DI-CAT-reporter system. (A) The names of the DI RNA
CAT reporters are shown on the left and their structures in the middle.
CAT activities expressed from these constructs, shown on the right,
represent fold-increase against the background, which is set as one-
fold (13). The CAT activities are representative of three independent
experiments. IG5–1 indicate the transcription initiation sites for
mRNA5–1. Only the 13-nt core sequence of the IG5–1 is shown. ORF, DI
open reading frame. Thick lines denote sequence of viral origin, while
the thin lines indicate their DI origin. (B) Reverse-transcription PCR was
performed to detect CAT-containing subgenomic mRNAs using CAT-
and leader-specific primers as described under Materials and Meth-
ods. Intracellular RNAs were isolated from MHV-infected and various
DI CAT RNA-transfected cells as indicated at the top. PCR products
were analyzed by electrophoresis on a 1% agarose gel. M, molecular
mass marker in base pair (bp) is shown on the left.
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80 ZHANG AND LIUcDNA containing the authentic 59-end of mRNA5–1 (in-
cluding the leader and ORF5b) was synthesized and
cloned into a plasmid vector (Fig. 5A). RNAs were then
synthesized by in vitro transcription with T7 RNA poly-
erase. Expression of ORF5b from mRNA5–1 was de-
ermined in an in vitro translation system. As shown in
ig. 5B, a protein with a molecular mass of approximately
–12 kDa, which corresponds to the predicted size of
RF5b, the E protein (Yu et al., 1994), was synthesized in
he rabbit reticulocyte lysate (lane IVT). This protein was
recipitated by an E-specific antibody (lane IVT 1 aE).
he reaction was specific because the same protein
ould not be precipitated by an unrelated antibody (the
2 monoclonal antibody against the Flag-epitope) (lane
VT 1 aFlag), or by protein G agarose beads alone (lane
VT 1 G). These results demonstrate that mRNA5–1 is a
unctional message and that it translates into the E
rotein.
Translational regulation of ORF5b in the DI RNA ex-
ression system. It was previously reported that the
RF5b of MHV was expressed from the second ORF of
RNA5 via an IRES (Thiel and Siddell, 1994, 1995). Our
urrent data showed that ORF5b could also be ex-
ressed from the first ORF of mRNA5–1 in an in vitro
ranslation reaction (Fig. 5). An obvious question then is
ow ORF5b is expressed in vivo (in virus-infected cells).
FIG. 5. In vitro translation of mRNA5–1. (A) The 59-end of viral
RNA5–1 was cloned into the plasmid under the control of T7 RNA
olymerase promoter (T7). Following restriction enzyme digestion with
otI, mRNAs were transcribed in vitro with T7 RNA polymerase in the
presence of a cap-analog. UTR, untranslated region; ORF5b, open
reading frame 5b, which encodes the E protein of MHV. (B) Result of in
vitro translation. The in vitro translation experiment was performed in
the rabbit reticulocyte lysate in the presence of 35S-methionine. Ten
microliters of in vitro translation products were precipitated with an
anti-E antibody (lane IVT 1 aE) or with an unrelated anti-Flag mono-
lonal antibody (lane IVT 1 aFlag) or without any antibody (lane IVT 1
G). Lane IVT represents 10% of the input volume of in vitro translation
roducts used for immunoprecipitation. Proteins were analyzed by
lectrophoresis on 17% SDS–polyacrylamide gel. The arrow indicates
he E protein. Prestained protein standard (Bio-Rad) was used as
olecular mass marker, which is shown in kilodaltons (kDa) on the left.o address this question, we made two sets of DI CAT
eporter constructs, both of which contain the authenticRF5a and the CAT gene in place of ORF5b. In the first
et, the IG5 consensus sequence and the 59-UTR are
resent, so that ORF5a would be expressed from
RNA5, while in the second set the ORF5a would not be
xpressed due to the absence of mRNA5 transcription
see their structures in Fig. 6). We then transfected these
I RNAs into JHM-infected cells. Detection of the CAT
ctivity would indicate the expression of the ORF5b from
hese reporter DI RNAs. As expected, high CAT activity
as detected in DECAT5-RNA-transfected cells (1384-
old increase over the background) (Fig. 6A). Interest-
ngly, the CAT activity expressed from DECAT5m RNA-
ransfected cells remained at a high level (921-fold above
ackground level), though it was slightly lower than that
f DECAT5. Because there was no subgenomic DI
RNA5–1 transcribed from DECAT5m (Fig. 6B), it is con-
eivable that the CAT activity must have been expressed
FIG. 6. Analyses of the expression of ORF5b using the defective-
interfering (DI) RNA-reporter system. (A) The names of the DI RNA CAT
reporters are shown on the left and their structures in the middle. CAT
activities expressed from these constructs, shown on the right, repre-
sent fold-increase against the background, which is set as onefold
(13). The CAT activities are representative of three independent ex-
periments. IG5 and IG5–1 indicate the transcription initiation sites for
mRNA5 and mRNA5–1, respectively. IG5–1m indicates two nucleotide
mutations in the IG5–1 sequence. ORF, DI open reading frame. Thick
lines denote the sequences derived from the viral genome; dashed
lines indicate deletions. (B) Reverse-transcription PCR was performed
to detect CAT-containing subgenomic mRNAs using CAT- and leader-
specific primers. RNAs were isolated from cells infected with a helper
MHV and transfected with various DI CAT RNAs as indicated at the top.
Lane Mock-Tx, mock-transfection. PCR products were analyzed by
electrophoresis on a 1% agarose gel. The solid arrow denotes PCR
products representing mRNAs transcribed from IG5 site, and the un-
filled arrow indicates mRNAs transcribed from IG5–1 site. M, molecular
mass marker in base pair (bp) is shown on the left.
81A NONCANONICAL SIGNAL FOR MHV RNA TRANSCRIPTIONfrom either DI mRNA5 or genomic DI RNA, in the latter of
which the CAT gene is the third ORF. In both cases, the
expression of the CAT activity must be mediated via
internal entry of ribosome. When the IG5 consensus
sequence was removed and the TIS5–1 was mutated
(construct DECAT5–1Lm), the CAT activity was drastically
reduced (164-fold above the background). Because nei-
ther DI mRNA5 nor DI mRNA5–1 was transcribed from
DECAT5–1Lm (Fig. 6B), the low level of CAT activity was
likely expressed from the genomic DI RNA via ribosomal
internal entry. However, when the wild-type IG5–1 se-
quence was restored (DECAT5–1L), CAT activity was
significantly increased (Fig. 6A). Because the wild-type
IG5–1 allowed the transcription of DI mRNA5–1 (Fig. 6B),
this result indicates that a large part of the CAT activity
was expressed from DI mRNA5–1 (compare the structure
and CAT activity of DECAT5–1L with those of DECAT5–
1Lm in Fig. 6). Taken together, these results indicate that
MHV ORF5b can be expressed from mRNA5, mRNA5–1,
and even the genomic RNA in vivo using the DI RNA
expression system.
DISCUSSION
In this study, we have identified a noncanonical se-
quence that allows the transcription of a novel sub-
genomic mRNA species (mRNA5–1) of JHM2c, JHM(2),
JHM(3), A59, and MHV-1. Using the MHV DI RNA-CAT
reporter system, we were able to demonstrate that the
noncanonical sequence serves as a signal for transcrip-
tion of a subgenomic mRNA (Fig. 3). Although the precise
sequence for this transcription signal was not deter-
mined, a 13-nt sequence including the leader-joining site
was shown to be sufficient for the expression of the DI
CAT reporter gene (Fig. 4). Furthermore, the three nucle-
otides at the leader-joining site appear to be required for
its transcription activity, since mutations of these nucle-
otides abolished subgenomic mRNA transcription (Fig.
4). The computer program MacVector predicts that this
novel mRNA species encodes the ORF5b of MHV at its
most 59-end. In vitro translation studies with the rabbit
reticulocyte lysate confirmed that the E protein is trans-
lated from this mRNA (Fig. 5), indicating that this mRNA
is a functional transcript. Our results thus establish for
the first time that a noncanonical sequence, which has
no sequence resemblance to the consensus IG se-
quence, can serve as a signal for transcription of a
functional mRNA in MHV. This finding will have important
implications not only in the mechanisms of coronavirus
RNA transcription but also in the regulation of coronavi-
rus gene expression both at the transcription and trans-
lation levels.
The major feature in coronavirus RNA transcription is
the discontinuous process. Regardless of whether the
discontinuous transcription occurs during (1)- or (2)-
strand synthesis, subgenomic RNA synthesis always in-volves the interaction between the leader (antileader)
and the intergenic sequence. It has been suggested that
this interaction is probably mediated by direct RNA–RNA
interaction between the complementary sequences (see
review by Lai and Cavanagh, 1997, and references
therein). Using MHV JHM2c, we previously showed that
mRNA2–1 of JHM2c is very heterogeneous at its leader-
body joining site (Zhang and Lai, 1994). In addition to
those mRNAs whose leader-body fusion occurs at the
consensus IG sequence, some mRNAs have a leader
fused at either upstream or downstream of the consen-
sus IG sequence. Because these upstream or down-
stream regions do not have complementary sequences
between the leader and the consensus IG site, it is less
likely that direct RNA–RNA interaction through comple-
mentary sequences is the major determinant for this
discontinuous process. While the previous observation
reveals a random fashion of the heterogeneous leader-
body fusion sites, our present data show a distinct,
conserved site, even though both studies have identified
noncanonical sequences for leader-body fusion. Thus,
our current finding reinforces the notion that direct RNA–
RNA base-pairing between the leader (antileader) and
the IG region is not the sole mechanism in regulating
coronavirus RNA transcription. If base-pairing guides
subgenomic RNA transcription as shown in arterivirus
(van Marle et al., 1999), then why the remaining consen-
sus sequences that are base-paired with the leader and
are distributed throughout the genomes of arteriviruses
and coronaviruses do not transcribe subgenomic
mRNAs. This fact combined with previous (Zhang and
Lai, 1994; Fischer et al., 1997) and current findings further
suggests that other mechanisms, i.e., protein–RNA and
protein–protein interactions and/or RNA secondary
structures (Zhang et al., 1994; Zhang and Lai, 1995; Lai,
1998), are likely involved in this discontinuous transcrip-
tion process.
With respect to the translation of ORF5b, our data
clearly show that, when the ORF was placed at the
59-most end of an mRNA (pBS-mRNA5–1), it could be
translated efficiently both in the rabbit reticulocyte lysate
in vitro translation system (construct pBS-mRNA5–1 in
Fig. 5) and in vivo in the DI RNA CAT-reporter system
(construct DECAT-5–1L in Fig. 6). These data suggest
that ORF5b is possibly expressed from mRNA5–1 via the
59 cap-dependent mechanism. However, we cannot rule
out the possibility of the cap-independent pathway be-
cause part of the IRES (Jendrach et al., 1999) is also
present in these mRNAs. When the CAT gene was
placed in the second ORF of mRNA5 (construct
DECAT5m in Fig. 6) or in the third ORF of genomic DI
RNA (construct DECAT5–1Lm in Fig. 6), the CAT gene
could also be expressed in vivo with the DI CAT-reporter
system. These results thus clearly indicate that ORF5b
can be expressed via internal ribosomal entry, consistent
with the finding by Thiel and Siddell (1994, 1995). Jen-
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82 ZHANG AND LIUdrach et al. (1999) reported that the IRES encompassing
region from approximately 100-nt upstream to 180-nt
ownstream of the ORF5b AUG start codon mediated the
ranslation of ORF5b. Our results showed that the pres-
nce of the upstream sequence alone is able to mediate
ts expression, albeit with low efficiency (Fig. 6). It is
mportant to point out that, although our experimental
esign was not intended to address the mechanism of
ranslation, the results presented here (Fig. 6) strongly
uggest that ORF5b can be expressed from mRNA5,
RNA5–1, and genomic RNA. This finding raises an
ntriguing question: Why does MHV use multiple path-
ays to regulate the expression of a single gene? To
ate, there is no clear answer to this question, but it is
nown that the expression of the E protein is diverse. For
xample, the E gene is expressed from the third ORF of
RNA3 in IBV, but from the first ORF of mRNA5–1 of
CoV and of mRNA4 of TGEV and HCoV 229E (Siddell,
995). Apparently, various coronaviruses have the ability
o use different mechanisms for expressing their E pro-
ein. Recently, O’Connor and Brian (2000) reported that in
GEV, ORF3b of the Purdue strain is expressed from the
irst ORF of mRNA3–1, whereas that of the Muller strain
s expressed from the second ORF of mRNA3.
Our results offer another interesting possibility that
RF5b may also be expressed from MHV genomic RNA
nd subgenomic mRNAs 2–4, since they contain the
RES sequence. When the CAT gene was placed as the
hird ORF in the DI, a low level of CAT activity was
xpressed (Fig. 6A). One possible explanation is that a
ow amount of CAT-containing subgenomic DI RNA was
ranscribed from the mutated IG5–1 site. However, our
ensitive RT-PCR could not detect any such mRNA (Fig.
B). Thus, a more reasonable explanation is that the CAT
ctivity is expressed from the genomic RNA via internal
ntry of ribosome. This is further supported by the data
btained with the DECAT5m construct. However, by com-
aring DECAT5–1L with DECAT5–1Lm (Fig. 6), one could
onclude that translation of the CAT gene from the
enomic DI RNA via internal entry of ribosome must be
ery inefficient. By analogy to the DI system, our results
uggest that the E gene can also be expressed from the
enomic RNA and subgenomic mRNAs 2–4, since they
ll contain the IRES, but that the efficiency of such trans-
ation is low. Further investigation on the mechanisms of
ranslation of ORF5b is needed.
It is worth noting that the detection of mRNA5–1 in
HM2c-infected cells is unlikely the result of RT-PCR
rtifact. We employed the same procedure for amplifying
arious mRNA species (mRNAs 2–7) and did not identify
uch conserved mRNA species (Zhang, 2000). By con-
rast, we were able to amplify mRNA5–1 repeatedly and
n an amount proportional to mRNA5 (data not shown).
owever, mRNA5–1 is a minor species relative to
RNA5 (Figs. 1 and 2). Interestingly, when Makino et al.
(1984) analyzed the intracellular viral mRNAs of JHM2c
p
gand its parental JHM strains, they found that a minor
mRNA species (named RNA c) migrated slightly faster
than mRNA5 on 1% agarose gel. They noted that it was
difficult to separate the major (mRNA5) from the minor
(RNA c) RNA species, but possible mixtures were notice-
able. Although RNA c was identified in both JHM and
JHM2c, it was predominantly present in JHM2c (Makino
et al., 1984). Sequence comparison also revealed that the
IG5–1 is conserved between JHM and JHM2c (data not
shown). Thus, it is tempting to speculate that mRNA5–1
identified in this study might represent RNA c detected
by Makino et al. (1984). However, RNA c-like mRNA
species was not found in A59 and MHV-1. Thus,
mRNA5–1 may represent a novel mRNA species.
MATERIALS AND METHODS
Cells, virus, and antibody. The murine astrocytoma cell
line DBT (Hirano et al., 1974) was used for virus growth,
virus infection, and RNA transfection. The naturally oc-
curring small plaque mutant JHM2c, the parental JHM(2),
and JHM(3) strains (Makino et al., 1984, 1988), A59, and
MHV-1 were used in this study. The goat antiserum
specific to MHV E protein was kindly provided by Dr.
Julian Leibowitz, University of Texas in College Station,
and its specificity was confirmed previously (Yu et al.,
994). The M2 monoclonal antibody specific to an eight-
mino acid flag-epitope was purchased from BAbCo, Inc.
Reverse transcription and polymerase chain reaction
nd cloning of viral subgenomic mRNAs. For detection of
iral subgenomic mRNAs, DBT cells were infected with
HM2c at a multiplicity of infection of 5. Virus grew in the
resence of actinomycin D (10 mg/ml). Intracellular RNAs
ere isolated from cells at 7 h postinfection by the
onidet P-40 method as described previously (Zhang et
l., 1994) and used for cDNA synthesis by RT with an
ntisense primer 39IG5–300 (59-GCG TAG GCC GTG AAG
TA-39). This primer is complementary to a sequence
pproximately 300 nucleotides downstream of the IG
onsensus sequence between genes 6 and 5 of viral
NAs. An additional sense primer (59L9) specific to the
eader (Zhang et al., 1994) was used for the subsequent
CR amplification. The conditions for the RT-PCR were
ssentially the same as described previously (Zhang and
ai, 1994). Briefly, the RT reaction was carried out at 42°C
or 90 min, and the PCR was performed in a thermocycler
DNA Engine PTC-200, M.J. Research) for 30 cycles. The
ondition for each cycle was denaturation at 95°C for
0 s, annealing at 62°C for 1 min, and extension at 72°C
or 1 min. For detection of subgenomic mRNAs contain-
ng the CAT reporter gene, RT-PCR was carried out using
CAT-specific antisense primer 39-CAT542 (59-TTA CGC
CC GCC CTG CCA CTC ATC GC-39, complementary to
he 39-end of the CAT ORF) and the leader-specific sense
rimer 59-L9. PCR products were analyzed by agarose
el electrophoresis either directly or after cloning and
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83A NONCANONICAL SIGNAL FOR MHV RNA TRANSCRIPTIONrestriction enzyme digestion as indicated. PCR products
were directly cloned into the pTOPO2.1 TA cloning vector
(In Vitrogen). For detecting mRNA5–1 in other MHV
strains [JHM(2), JHM(3), A59 and MHV-1], the antisense
primer 39-IG6–50 (59-GCT GTC CAT TGG TAG ACG-39,
complementary to a sequence at nt 30–47 of the ORF6)
was used for RT reaction and the primer pair 59-L9 and
39-IG6–50 for PCR.
Analysis and sequencing of cDNA clones. All cDNA
clones for JHM2c were analyzed by restriction enzyme
digestion and agarose gel electrophoresis. RT-PCR prod-
ucts representing cDNA fragments derived from JHM(2),
JHM(3), A59, and MHV-1 were purified from agarose gel
with the gel extraction kit (GelExII, Qiagen) and used
directly for DNA sequencing. Sequences were deter-
mined with the automatic DNA sequencer (Model Prizm
377, ABI) in the core facility of the Department of Micro-
biology and Immunology, UAMS. For sequencing of the
cloned DNA, either the T7 promoter primer or the M13
reverse primer was used; for direct sequencing of PCR
fragments, primer 39-IG6–50 was used.
Plasmid constructions. For generating a DI CAT re-
porter plasmid containing the IG5–1 sequence (upstream
of ORF5b), a three-step jumping PCR was performed. In
the first PCR, pTA-IG5–370 DNA was used as a template.
pTA-IG5–370 contains the 59-end 370 nt of mRNA5,
hich was cloned after RT-PCR amplification (see Figs. 1
nd 2). The sense primer was 59-SpeIG5–1 (59-TTA CTA
TT GTG AGT GAC GCC T-39), which contains a SpeI site
t the 59-end (italic) and a sequence at nt 81–95 down-
tream of the consensus IG5 site. The antisense primer
as 39-IG5–1 CAT (59-ATT TTT TTC TCC ATA CCC TGG
TG CTA CA-39), which contains a sequence from nt 206
o 221 downstream of the consensus IG5 and the first 14
t of the CAT ORF (italic). In the second PCR, the CAT
RF was amplified from the pDECAT2–1 DNA template
Zhang et al., 1994) with the primer pair 59-CAT (59-ATG
GAG AAA AAA AT-39) and 39CAT542. Products from these
two PCR reactions were purified with the Gel Elution Kit
(Qiagen) following agarose gel electrophoresis and were
used as templates for a third PCR with the primer pair
59SpeIG5–1 and 39-CAT542. The final PCR products were
digested with SpeI and BspEI, and they were direction-
ally cloned into the SpeI and BspEI sites of pDECAT2–1,
generating pDECAT5–1(140). This construct contains 140
nt of the IG5–1 sequence in front of the CAT ORF. For
making two deletion constructs, pDECAT5–1(140) was
used as a template for PCR amplification with the primer
pair 59-SpeIG5–1D63 and 39CAT542, and 59-SpeIG5–
1D76 and 39CAT542, respectively. 59-SpeIG5–1D63 (59-
TTA CTA GTG CTT CCA ATT TAA-39) contains a SpeI site
(italic) and a sequence at nt 144–156 downstream of the
IG5 consensus sequence. 59-SpeIG5–1D76 (59-TTA CTA
GTT ATT GCC AAC CCC GA-39) contain a SpeI site at the
9-end (italic), and a sequence at nt 157–172 downstream
f IG5 consensus sequence. The PCR products wereigested with SpeI and BspEI, and directionally cloned
nto the SpeI and BspEI sites of pDECAT2–1, resulting in
pDECAT5–1D63 and pDECAT5–1D76, respectively (Fig.
4). For creating DI CAT reporter constructs containing the
13-nt core sequence and its mutant, DNAs were synthe-
sized from the pDECAT2–1 DNA templates by PCR with
the primer pairs 59-SpeIG5–1(13)CAT (59-TTA CTA GTG
TT CCA ATT TAA ATG GAG AAA AAA AT-39) and 39-
AT542, and 59-SpeIG5–1(13)CGC-CAT (59-TTA CTA GTG
TT CCC GCT TAA ATG GAG AAA AAA AT-39) and
39-CAT542, respectively. Both 59-primers contain a SpeI
site at the 59-end (italic) and the first 14 nucleotides of the
CAT ORF at the 39-end. While 59-SpeIG5–1(13)CAT con-
tains the wild-type, core 13-nt sequence downstream of
the IG5 consensus sequence, 59-SpeIG5–1(13)CGC-CAT
has 3-nt mutations within this core sequence (double-
underlined). PCR fragments were digested with SpeI and
BspEI and directionally cloned into pDECAT2–1, resulting
in pDECAT5–1(13) and pDECAT5–1(13)m, respectively
(Fig. 4).
To construct pDECAT5 (Fig. 6), RT-PCR was performed
to generate cDNA fragments encoding the 5a gene from
JHM2c RNA with the sense primer 59-IG5–70 (59-GTC
TAC CTT GGT AGT TCA A-39, corresponding to nt 70 to
53 upstream of the IG5 consensus sequence) and the
antisense primer 39-IG5abCAT [59-ATT TTT TTC TCC ATT
AAA TTA AAC ATT TC-39, complementary to the first 14 nt
of CAT ORF (italic) and a sequence at the overlapping
junction between JHM2c ORF 5a and 5b]. In the second
PCR, the CAT ORF was synthesized with primers 59-CAT
and 39-CAT542. PCR products were purified with the Gel
Elution Kit (Qiagen) following agarose gel electrophore-
sis and used as templates for a third PCR with the primer
pair 59-IG5–70 and 39-CAT542. The PCR products were
digested with SpeI (a natural SpeI site present immedi-
ately upstream of the IG5 consensus sequence) and
BspEI, and the digested fragments were directionally
cloned into the SpeI and BspEI sites of pDECAT2–1,
generating pDECAT5. To create mutant pDECAT5m (Fig.
6), an upstream DNA fragment was amplified from
pDECAT5 DNA templates with the sense primer 59-
IG5–70 and an antisense primer 39-IG5bMCG [59-AAC
GGG AAG CAA AAA TCT-39, complementary to a se-
quence at the IG5–1 site with 2-nt mutations (double-
underlined)]. An overlapping downstream DNA fragment
was amplified from the same templates with the sense
primer 59-IG5bMCG [59-UUU UGC UUC CCG UUU AAU
UAU UGC CA-39, corresponding to a sequence at IG5–1
site with 2-nt mutations (double-underlined)] and the
antisense primer 39-CAT542. These two PCR fragments
were purified and used as templates for the third PCR, in
which the primer pair 59-IG5–70 and 39-CAT542 was
used. Products were cloned into the pDECAT2–1 in the
same manner as for pDECAT5. For constructing
pDECAT5–1L and pDECAT5–1Lm, PCR was performed
with the pair of primers (59-SpeIG5–1 and 39-CAT542) on
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84 ZHANG AND LIUthe template DNAs of pDECAT5 and pDECAT5m, respec-
tively. The PCR products were digested with SpeI and
BspEI and directionally cloned into the pDECAT2–1. Mu-
tations of these clones were confirmed by DNA sequenc-
ing.
For in vitro transcription and translation study, a plas-
id containing the 59-end authentic mRNA5–1 sequence
was constructed in three steps. First, a cDNA was syn-
thesized with RT-PCR with the sense primer 59SpeIG5–1
and the antisense primer 39IG6–50. PCR products were
digested with DraI to remove the 59-end sequence of
’115 nt. Second, PCR was performed to generate a
cDNA containing the 59-end of mRNA5–1 using pTA-
mRNA5–1 DNA as a template, which was cloned in the
pTOPO2.1 TA vector (see Figs. 1 and 2). The primer pair
was T7 promoter primer and 39IG5–300. Third, DNA frag-
ments from the first and second PCR were mixed and
used as templates for a third PCR, in which the primer
pair (the sense T7 promoter primer and the antisense
primer 39IG6–50) was used. PCR fragments were di-
gested with SnaBI and blunt-ended with T4 DNA poly-
merase and used for cloning. pDECAT2–1 DNA was
digested with SnaBI and XbaI to remove all but the
59-end 24-nt of the DI RNA, blunt-ended, and used as a
vector for cloning of the above PCR fragments. The
resultant plasmid pBS-mRNA5–1 contains the 59-end of
RNA5–1 with the complete ORF5b (Fig. 5).
In vitro transcription and RNA transfection. For gener-
ting DI RNA for transfection, plasmid DNAs were linear-
zed with XbaI. RNAs were transcribed with T7 RNA
olymerase using the MegaScript in vitro transcription kit
ccording the manufacturer’s instruction (Ambion). For
enerating mRNAs for in vitro translation study, plasmid
NAs were linearized with XbaI. Capped mRNAs were
ranscribed with the MegaScript kit in the presence of
ap-analog (BRL-Gibco). DNA templates were digested
ith RQ DNase I (Promega). mRNAs were purified with
25 column (Ambion). The in vitro transcribed DI RNAs
ere transfected into MHV-infected DBT cells with the
ransfection reagent DOTAP according to the manufac-
urer’s instruction (Boehringer Mannheim) as described
reviously (Zhang and Lai, 1994).
Extraction of cell lysate and CAT assay. Infected and
ransfected DBT cells from a 60-mm Petri dish were
arvested at 8 h p.i. in most experiments, resuspended in
50 ml of 0.25 M Tris–HCl (pH 8.0), and lysed by freezing
and thawing three times. Cellular lysate was incubated
at 60°C for 10 min. Following a brief centrifugation, 50 ml
f each sample was assayed for CAT activity using an
ssay kit according to the manufacturer’s instructions
Promega). The CAT reaction was carried out for 12 h as
escribed previously (Zhang et al., 1994).
In vitro translation. The in vitro translation reaction was
carried out in the nuclease-treated rabbit reticulocyte
lysate system in the presence of 35S-methionine usinghe in vitro transcribed RNAs according to the manufac-
urer’s recommendations (Promega).
Immunoprecipitation. Immunoprecipitation was car-
ied out in 200 ml of radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5%
NP-40, 0.1% SDS, 1 mM PMSF) containing 10 ml of the in
vitro translation products and 1 ml of the goat-anti-E
olyclonal antiserum by constant rocking on a rocking
latform at 4°C overnight. The antibody-antigen com-
lexes were then precipitated with protein G-agarose
eads (Boehringer Mannheim) at 4°C for 2 h. Agarose
eads were washed 3–5 times with RIPA buffer. Protein
omplexes were denatured by boiling for 3 min in Lam-
eli’s sample loading buffer (100 mM Tris, pH 6.8, 200
M DTT, 4% SDS, 0.2% bromphenal blue, 20% glycerol)
nd analyzed by SDS-polyacrylamide gel electrophore-
is. The gels were exposed to X-ray film and autoradio-
raphed.
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